Skip to main content
. 2022 Jan 15;35(1):87–104. doi: 10.1007/s10334-021-00994-1

Fig. 7.

Fig. 7

In vivo 2OMG and 6DG CEST MRI measurements in 4T1 tumors (7 T field). A, C T2-RARE anatomical images before administration of the agents. B, D MTRasym images at 1.0 and 1.2 ppm following treatment with 2OMG (3 g/kg, IP) and 6DG (2.0 g/kg, IP), respectively, overlaid onto the T2 anatomical image. From [44], with permission